Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7)

Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, Kurzeder C, Higgins MJ, Connolly RM, Baron-Hay S, Gión M, Guarneri V, Bianchini G, Wildiers H, Escrivá-de-Romaní S, Prahladan M, Bridge H, Kuptsova-Clarkson N, Scotto N, Verma S, Lin NU, Anders C, Hall P, Zaman K, Aebi S, Rossi L, Klint L, Killander F, Schiza A, del Prado PM, González CH, Flores EG, Sanchez CR, López RL, Castán JC, Borrego MR, Marti MPL, Gregori JG, Manich CS, Losada MJV, Sousa AR, Cardoso F, Simões J, Duchnowska R, Jassem J, Radecka B, Nowecki Z, Wysocki P, Sætersdal A, Engebråten O, Pilskog M, Houtsma D, de Boer M, Tomioka N, Tsugawa K, Tsurutani J, Yamashita T, Fotia V, Biganzoli L, Berardi R, Caruso M, De Laurentiis M, McCaffrey J, van Mackelenbergh M, Marmé F, Grischke EM, Braun M, Tio J, Park-Simon TW, Fasching P, Untch M, Tesch H, Reinisch M, Wimberger P, Huovinen R, Mattson J, Tanner M, Brix E, Rønlev J, Maraldo M, Chia S, Jerzak K, De Cuypere E, Collignon J, Gombos A, Murray N, Clay T, McCartney A, McCarthy N, Yeo B (2024)

Publication Type: Journal article, Erratum

Publication year: 2024

Journal

Book Volume: 30

Pages Range: 3780-

Journal Issue: 12

DOI: 10.1038/s41591-024-03349-0

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03261-7, published online 13 September 2024. In the version of this article initially published, members of the DESTINY-Breast12 study group were not included by the journal in the full text. In Table 1, under the “Prior CNS therapies n (%)” section, seven rows have been added, in addition to the original CNS radiotherapy, WBRT and SRS rows. In Table 1 and in the Results: Patients section, “intracranial therapy” has been amended to “CNS radiotherapy,” while the text “the type of intracranial radiotherapy was not always recorded by investigators, and only WBRT and SRS intracranial radiotherapy were reported” has been removed. All changes appear in the HTML and PDF versions of the article.

Authors with CRIS profile

Involved external institutions

Centre Hospitalier Universitaire de Liège (CHU Liège) Belgium (BE) Universitätsspital Basel Switzerland (CH) Royal North Shore Hospital (RNSH) Australia (AU) University College Cork (UCC) Ireland (IE) Tokai University / 東海大学 (Tōkai Daigaku) Japan (JP) Medizinische Universität Wien Austria (AT) Hospital Beata María Ana Spain (ES) Universitätsklinikum Hamburg-Eppendorf (UKE) Germany (DE) St Vincent's University Hospital Ireland (IE) Hospital Universitario 12 de Octubre Spain (ES) British Columbia Cancer Agency Canada (CA) Odense Universitetshospital (OUH) Denmark (DK) Sunnybrook Health Sciences Centre Canada (CA) Kliniken Essen-Mitte Germany (DE) Ospedale San Raffaele (früher: Centro San Raffaele del Monte Tabor Foundation) Italy (IT) Rigshospitalet Denmark (DK) Universitätsklinikum Münster Germany (DE) AstraZeneca UK Limited United Kingdom (GB) Ruber International Hospital Spain (ES) Agaplesion Markus Krankenhaus Germany (DE) Turku University Hospital / Turun yliopistollinen keskussairaala (TYKS) Finland (FI) Hospital Universitario de La Princesa Spain (ES) MonashHeart (formerly: Cardiology, Monash Medical Centre) Australia (AU) Vall d'Hebron University Hospital / Hospital Universitari Vall d'Hebron Spain (ES) HagaZiekenhuis Netherlands (NL) GenesisCare Australia (AU) Maastricht University Netherlands (NL) Universitätsklinikum Carl Gustav Carus Dresden Germany (DE) University of Padua / Universita degli Studi di Padova Italy (IT) Gentofte Hospital Denmark (DK) Institut Jules Bordet Belgium (BE) Medizinische Hochschule Hannover (MHH) / Hannover Medical School Germany (DE) Duke University Medical Center United States (USA) (US) HUSLAB Finland (FI) AZ Sint-Jan Belgium (BE) University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven Belgium (BE) Austin Health Australia (AU) Haukeland University Hospital / Haukeland universitetssykehus Norway (NO) Tampere University Hospital / Tampereen yliopistollinen sairaala (TAYS) Finland (FI) Universitätsklinikum Tübingen Germany (DE) Centro Hospitalar de Lisboa Central Portugal (PT) Hospitales Universitarios Virgen Macarena y Virgen del Rocío Spain (ES) St John of God Subiaco Hospital Australia (AU) Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV) Switzerland (CH) Humanitas Istituto Clinico Catanese Italy (IT) Sahlgrenska University Hospital / Sahlgrenska Universitetssjukhuset Sweden (SE) Uppsala University Hospital / Akademiska sjukhuset Sweden (SE) Hospital de Basurto Spain (ES) Complejo Hospitalario Universitario de Santiago de Compostela Spain (ES) Kanagawa Prefectural Hospital / Kanagawa Cancer Center / 神奈川県立がんセンター Japan (JP) Western General Hospital United Kingdom (GB) Bellvitge University Hospital / Hospital Universitari de Bellvitge Spain (ES) Ruprecht-Karls-Universität Heidelberg Germany (DE) Skåne University Hospital / Skånes universitetssjukhus Sweden (SE) Complejo Hospitalario de Salamanca / Complejo Asistencial Universitario de Salamanca Spain (ES) Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" Italy (IT) Opolskie Centrum Onkologii im. prof. Tadeusza Koszarowskiego w Opolu Poland (PL) Valencia Oncology Institute Foundation / Fundación Instituto Valenciano de Oncología / Fundació Institut Valencià d’Oncologia (IVO) Spain (ES) Showa University Hospitals Japan (JP) Oslo University Hospital / Oslo Universitetssykehus Rikshospitalet Norway (NO) Universidade do Porto Portugal (PT) National Hospital Organization Hokkaido Medical Center / 独立行政法人 国立病院機構 北海道医療センター Japan (JP) Mater Misericordiae University Hospital (MMUH) / Ospidéal an Mater Misercordiae Ireland (IE) Complejo Hospitalario Universitario de Granada Spain (ES) Ospedale Misericordia e Dolce Italy (IT) Icon Group Australia (AU) Champalimaud Foundation / Fundação Champalimaud Portugal (PT) Azienda Ospedaliera Papa Giovanni XXIII Italy (IT) Hospital Clínic de Barcelona Spain (ES) HELIOS Kliniken Germany (DE) Szpital Uniwersytecki w Krakowie Poland (PL) Wojskowy Instytut Medyczny Poland (PL) St. Marianna University School of Medicine / 聖マリアンナ医科大学 Japan (JP) Luzerner Kantonsspital (LUKS) Switzerland (CH) Ente Ospedaliero Cantonale Switzerland (CH) Dana-Farber Cancer Institute United States (USA) (US) Maria Skłodowska-Curie Institute of Oncology / Centrum Onkologii–Instytut im. Marii Skłodowskiej-Curie w Warszawie Poland (PL) European Institute of Oncology / Istituto Europeo di Oncologia (IEO) Italy (IT) Universitätsklinikum Schleswig-Holstein (UKSH) Germany (DE) Rotkreuzklinikum München Germany (DE) Klinikum der Universität München (LMU Klinikum) Germany (DE) Marqués de Valdecilla University Hospital / Hospital Universitario de Marqués de Valdecilla (HUMV) Spain (ES) Azienda Ospedaliero Universitaria Ospedali Riuniti Ancona Italy (IT)

How to cite

APA:

Harbeck, N., Ciruelos, E., Jerusalem, G., Müller, V., Niikura, N., Viale, G.,... Yeo, B. (2024). Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7). Nature Medicine, 30(12), 3780-. https://doi.org/10.1038/s41591-024-03349-0

MLA:

Harbeck, Nadia, et al. "Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7)." Nature Medicine 30.12 (2024): 3780-.

BibTeX: Download